Skip to content
healthcare.dev

ILUMYA

NDC 47335-177, tildrakizumab-asmn, injection, solution, from Sun Pharmaceutical Industries, Inc..

Product NDC
47335-177
Status
Listed
Labeler
Sun Pharmaceutical Industries, Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761067
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/47335-177 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TILDRAKIZUMAB100 mg/mL

Pharmacologic classes

Interleukin-23 Antagonist [EPC]; Interleukin-23 Antagonists [MoA]

Package NDCNDC-11Package
47335-177-01473350177011 mL in 1 SYRINGE, GLASS (47335-177-01)
47335-177-10473350177101 mL in 1 CARTON (47335-177-10)
47335-177-95473350177951 mL in 1 CARTON (47335-177-95)
47335-177-96473350177961 mL in 1 SYRINGE, GLASS (47335-177-96)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c6a322bb-51b9-4f0e-8642-62a9682ffcde
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=47335-177

Use it

Look up 47335-177 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/47335-177 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 47335-177. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.